Karyopharm Therapeutics Inc.
US ˙ NasdaqGS ˙ US48576U1060

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Barry E Greene. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Barry E Greene har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:SAGE / Sage Therapeutics, Inc. President and CEO, Director 0
US:KPTI / Karyopharm Therapeutics Inc. Director 13.606
US:ACOR / Acorda Therapeutics, Inc. Director 10.000
US:ALNY / Alnylam Pharmaceuticals, Inc. President 0
US:RGLS / Regulus Therapeutics Inc. Director, 10% Owner 25.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Barry E Greene. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb KPTI / Karyopharm Therapeutics Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i KPTI / Karyopharm Therapeutics Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2015-04-02 KPTI Greene Barry E 3.000 29,3128 200 439,6920 87.938 14 34.8300 -80.972 -92,08

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KPTI / Karyopharm Therapeutics Inc. Insider Trades
Insidersalg KPTI / Karyopharm Therapeutics Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i KPTI / Karyopharm Therapeutics Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KPTI / Karyopharm Therapeutics Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Barry E Greene som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-07-31 2025-07-31 4 SAGE Sage Therapeutics, Inc.
Common Stock
D - Sale to Issuer -53.229 0 -100,00
2025-07-31 2025-07-31 4 SAGE Sage Therapeutics, Inc.
Common Stock
U - Other -46.940 0 -100,00
2025-04-11 2025-04-10 4 SAGE Sage Therapeutics, Inc.
Common Stock
F - Taxes -4.862 100.169 -4,63 6,91 -33.596 692.168
2025-04-11 2025-04-10 4 SAGE Sage Therapeutics, Inc.
Common Stock
A - Award 19.964 105.031 23,47
2024-08-07 2024-08-05 4 SAGE Sage Therapeutics, Inc.
Common Stock
F - Taxes -12.273 85.067 -12,61 8,96 -109.966 762.200
2024-08-07 2024-08-05 4 SAGE Sage Therapeutics, Inc.
Common Stock
A - Award 50.400 97.340 107,37
2022-11-15 2022-11-10 4 SAGE Sage Therapeutics, Inc.
Common Stock
P - Purchase 14.500 46.940 44,70 34,48 500.022 1.618.693
2022-08-15 2022-08-11 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise 7.576 13.606 125,64 1,48 11.250 20.205
2022-05-20 2022-05-19 4 KPTI Karyopharm Therapeutics Inc.
Nonstatutory Stock Option (right to buy)
A - Award 23.900 23.900
2022-02-15 2022-02-11 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 69.920 69.920
2021-08-09 2021-08-05 4 SAGE Sage Therapeutics, Inc.
Common Stock
P - Purchase 23.640 32.440 268,64 43,15 1.020.054 1.399.770
2021-06-17 2021-06-16 4 SAGE Sage Therapeutics, Inc.
Common Stock
P - Purchase 8.800 8.800 56,32 495.627 495.627
2021-06-04 2021-06-02 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 10.000 10.000
2021-05-21 2021-05-21 4 KPTI Karyopharm Therapeutics Inc.
Nonstatutory Stock Option (right to buy)
A - Award 23.900 23.900
2021-01-06 2021-01-04 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 390.000 390.000
2020-10-05 2020-10-01 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 20.000 20.000
2020-09-11 2020-09-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -44.530 0 -100,00
2020-09-11 2020-09-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.346 70.343 -4,54 124,38 -416.175 8.749.262
2020-09-11 2020-09-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -27.109 73.689 -26,89 123,39 -3.344.980 9.092.486
2020-09-11 2020-09-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14.075 100.798 -12,25 122,66 -1.726.440 12.363.883
2020-09-11 2020-09-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 44.530 114.873 63,30 9,14 407.004 1.049.939
2020-09-11 2020-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift -3.176 0 -100,00
2020-09-11 2020-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift -155 3.176 -4,65
2020-09-11 2020-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift -155 3.176 -4,65
2020-09-11 2020-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift 155 155
2020-09-11 2020-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift 3.176 65.412 5,10
2020-08-11 2020-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1.036 46.589 -2,18
2020-08-11 2020-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1.124 38.876 -2,81
2020-08-11 2020-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1.587 88.413 -1,76
2020-08-11 2020-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1.184 23.816 -4,74
2020-08-11 2020-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.184 67.167 1,79 42,22 49.988 2.835.791
2020-08-11 2020-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.124 65.983 1,73 88,95 99.980 5.869.188
2020-08-11 2020-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.036 64.859 1,62 96,45 99.922 6.255.651
2020-08-11 2020-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.587 63.823 2,55 63,00 99.981 4.020.849
2020-07-09 2020-07-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -22.265 44.530 -33,33
2020-07-09 2020-07-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -22.265 62.236 -26,35 159,99 -3.562.177 9.957.138
2020-07-09 2020-07-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 22.265 84.501 35,78 9,14 203.502 772.339
2020-06-17 2020-06-15 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 15.000 15.000
2020-05-26 2020-05-21 4 KPTI Karyopharm Therapeutics Inc.
Nonstatutory Stock Option (right to buy)
A - Award 16.400 16.400
2020-05-07 2020-05-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -22.265 66.795 -25,00
2020-05-07 2020-05-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -22.265 62.236 -26,35 149,99 -3.339.527 9.334.778
2020-05-07 2020-05-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 22.265 84.501 35,78 9,14 203.502 772.339
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -64 62.236 -0,10 106,65 -6.826 6.637.469
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.599 62.300 -2,50 104,75 -167.495 6.525.925
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5.417 63.899 9,26
2020-03-17 2020-03-13 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -3.030 0 -100,00
2020-03-17 2020-03-13 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise 3.030 6.030 101,00 0,03 100 199
2020-02-28 2020-02-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 29.925 29.925
2019-12-26 2019-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 9.999 19.998 100,00
2019-11-26 2019-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 9.999 9.999
2019-10-24 2019-10-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other -5.544 3.486 -61,40
2019-10-24 2019-10-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 5.544 58.482 10,47
2019-10-24 2019-10-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -58.913 0 -100,00
2019-10-24 2019-10-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -58.913 52.938 -52,67 89,99 -5.301.581 4.763.891
2019-10-24 2019-10-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 58.913 111.851 111,29 16,43 967.941 1.837.712
2019-08-07 2019-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 25.000 33,33
2019-08-07 2019-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 10.000 40.000 33,33 88,95 889.500 3.558.000
2019-08-07 2019-07-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 46 3.003 1,56
2019-06-21 2019-06-19 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 15.000 15.000
2019-06-07 2019-06-06 4 KPTI Karyopharm Therapeutics Inc.
Nonstatutory Stock Option (right to buy)
A - Award 25.000 25.000
2019-06-07 2019-06-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 18.750 50,00
2019-06-07 2019-04-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 52 2.957 1,79
2019-06-07 2018-10-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 21 2.905 0,73
2019-03-01 2019-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 32.500 32.500
2018-09-28 2018-09-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 12.500 100,00
2018-09-28 2018-09-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 10.000 30.000 50,00
2018-08-23 2018-08-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 10.000 20.000 100,00
2018-08-14 2018-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2014 (right to buy)
A - Award 15.875 47.625 50,00
2018-08-14 2018-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2013 (right to buy)
A - Award 15.000 45.000 50,00
2018-08-14 2018-07-31 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift 9.030 9.030
2018-08-14 2018-07-31 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift -9.030 52.938 -14,57
2018-08-14 2018-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 29 2.884 1,02
2018-08-14 2018-04-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 28 2.855 0,99
2018-08-14 2018-01-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 17 2.827 0,60
2018-06-29 2018-06-27 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 15.000 15.000
2018-06-20 2018-06-19 4 KPTI Karyopharm Therapeutics Inc.
Nonstatutory Stock Option (right to buy)
A - Award 17.000 17.000
2018-05-23 2018-05-21 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
M - Exercise -10.000 0 -100,00
2018-05-23 2018-05-21 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
F - Taxes -8.727 1.273 -87,27 23,10 -201.594 29.406
2018-05-23 2018-05-21 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
M - Exercise 10.000 10.000 20,16 201.600 201.600
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.300 61.968 -2,05 145,41 -189.033 9.010.767
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.165 63.268 -12,65 144,67 -1.325.901 9.152.982
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.644 72.433 -10,66 143,58 -1.241.106 10.399.930
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.217 81.077 -10,21 142,68 -1.315.082 11.568.066
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.250 90.294 -7,43 141,74 -1.027.615 12.798.272
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.884 97.544 -2,87 140,43 -405.000 13.698.104
2018-03-05 2018-03-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 30.000 30.000
2017-12-21 2017-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 6.250
2017-11-08 2017-11-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 10.000 10.000
2017-10-04 2017-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -85.316 0 -100,00
2017-10-04 2017-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -85.316 100.428 -45,93 125,00 -10.664.500 12.553.500
2017-10-04 2017-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 85.316 185.744 84,95 21,35 1.821.497 3.965.634
2017-09-22 2017-09-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -5.359 94.641 -5,36
2017-09-22 2017-09-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -6.485 85.915 -7,02
2017-09-22 2017-09-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.359 100.428 5,64 18,66 99.999 1.873.986
2017-09-22 2017-09-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6.485 95.069 7,32 7,10 46.044 674.990
2017-09-22 2017-09-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -76.815 0 -100,00
2017-09-22 2017-09-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2013 (Right to Buy)
A - Award 15.000 15.000
2017-09-22 2017-09-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -76.815 88.584 -46,44 100,00 -7.681.500 8.858.400
2017-09-22 2017-09-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 76.815 165.399 86,71 31,39 2.411.223 5.191.875
2017-08-03 2017-08-01 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
M - Exercise X -10.000 0 -100,00
2017-08-03 2017-08-01 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
S - Sale X -10.000 0 -100,00 21,57 -215.697
2017-08-03 2017-08-01 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
M - Exercise X 10.000 10.000 18,21 182.100 182.100
2017-07-11 2017-07-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2014 (right to buy)
A - Award 15.875 31.750 100,00
2017-06-16 2017-06-15 4 KPTI Karyopharm Therapeutics Inc.
Nonstatutory Stock Option (right to buy)
A - Award 17.000 17.000
2017-06-02 2017-05-31 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 15.000 15.000
2017-02-13 2017-02-09 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
M - Exercise X -723 0 -100,00
2017-02-13 2017-02-09 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
S - Sale X -723 0 -100,00 22,65 -16.376
2017-02-13 2017-02-09 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
M - Exercise X 723 723 22,13 16.000 16.000
2017-01-05 2017-01-03 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
M - Exercise X -3.017 0 -100,00
2017-01-05 2017-01-03 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
S - Sale X -3.017 0 -100,00 19,26 -58.113
2017-01-05 2017-01-03 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
M - Exercise X 3.017 3.017 15,91 48.000 48.000
2016-12-22 2016-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25.000 25.000
2016-12-05 2016-12-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -55.605 0 -100,00
2016-12-05 2016-12-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -500 88.584 -0,56 44,07 -22.036 3.904.074
2016-12-05 2016-12-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -16.976 89.084 -16,01 43,28 -734.747 3.855.689
2016-12-05 2016-12-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14.349 106.060 -11,92 42,61 -611.345 4.518.729
2016-12-05 2016-12-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 55.605 120.409 85,80 22,75 1.265.014 2.739.305
2016-06-17 2016-06-16 4 KPTI Karyopharm Therapeutics Inc.
Nonstatutory Stock Option (right to buy)
A - Award 10.000 10.000
2016-06-10 2016-06-08 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 15.000 15.000
2016-03-28 2016-03-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -8.940 89.060 -9,12
2016-03-28 2016-03-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -7.600 92.400 -7,60
2016-03-28 2016-03-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7.600 64.804 13,29 7,10 53.960 460.108
2016-03-28 2016-03-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8.940 57.204 18,52 9,14 81.712 522.845
2016-02-03 2016-02-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2014 (right to buy)
A - Award 15.875 15.875
2015-12-22 2015-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 40.000 40.000
2015-12-22 2015-11-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift -2.100 48.264 -4,17
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -3.185 76.815 -3,98
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -4.684 85.316 -5,20
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -6.087 58.913 -9,36
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -2.000 98.000 -2,00
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -4.395 0 -100,00
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -6.621 0 -100,00
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.000 50.364 4,14 9,14 18.280 460.327
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6.087 48.364 14,40 16,43 100.009 794.621
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.684 42.277 12,46 21,35 100.003 902.614
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3.185 37.593 9,26 31,39 99.977 1.180.044
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.395 34.408 14,64 22,75 99.986 782.782
2015-08-06 2015-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6.621 30.013 28,30 13,12 86.868 393.771
2015-06-11 2015-06-09 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 15.000 15.000
2015-05-28 2015-05-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -67.379 6.621 -91,05
2015-05-28 2015-05-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -67.379 23.392 -74,23 125,00 -8.422.375 2.924.000
2015-05-28 2015-05-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 67.379 90.771 288,04 13,12 884.012 1.190.916
2015-05-26 2015-05-22 4 KPTI Karyopharm Therapeutics Inc.
Nonstatutory Stock Option (right to buy)
A - Award 10.000 10.000
2015-05-05 2015-05-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 47.625 47.625
2015-04-06 2015-04-02 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
P - Purchase 3.000 3.000 29,31 87.938 87.938
2014-12-22 2014-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -1.000 74.000 -1,33
2014-12-22 2014-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.000 23.392 4,47 13,12 13.120 306.903
2014-12-22 2014-12-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11.200 22.392 -33,34 100,00 -1.120.000 2.239.200
2014-12-16 2014-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option (right to buy)
A - Award 15.000 15.000
2014-11-19 2014-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -33.200 0 -100,00
2014-11-19 2014-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 33.592 -0,30 93,99 -9.399 3.157.312
2014-11-19 2014-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.462 33.692 -13,95 90,96 -496.818 3.064.591
2014-11-19 2014-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.579 39.154 -19,66 89,80 -860.242 3.516.225
2014-11-19 2014-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -18.059 48.733 -27,04 89,11 -1.609.321 4.342.822
2014-11-19 2014-11-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 33.200 66.792 98,83 6,78 225.096 452.850
2014-11-13 2014-11-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -11.100 33.200 -25,06
2014-11-13 2014-11-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11.100 33.592 -24,84 100,00 -1.110.000 3.359.200
2014-11-13 2014-11-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 11.100 44.692 33,04 6,78 75.258 303.012
2014-07-09 2014-07-08 4 KPTI Karyopharm Therapeutics Inc.
Nonstatutory Stock Option (right to buy)
A - Award 10.000 10.000
2014-06-09 2014-06-05 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 10.000 10.000
2014-02-04 2014-02-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -19.500 44.300 -30,56
2014-02-04 2014-02-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.680 33.592 -4,76 78,68 -132.182 2.643.019
2014-02-04 2014-02-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 19.500 35.272 123,64 6,78 132.210 239.144
2013-12-18 2013-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 90.000 90.000
2013-12-18 2013-12-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -11.200 47.796 -18,98
2013-12-18 2013-12-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11.200 15.772 244,97 6,78 75.936 106.934
2013-10-22 2013-10-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 10.000 10.000
2013-06-03 2013-05-30 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 10.000 10.000
2013-05-30 2013-05-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -14.928 0 -100,00
2013-05-30 2013-05-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -7.894 0 -100,00
2013-05-30 2013-05-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14.928 4.572 -76,55 30,00 -447.840 137.160
2013-05-30 2013-05-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 14.928 19.500 326,51 0,95 14.182 18.525
2013-05-30 2013-05-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.894 4.572 -63,32 30,00 -236.820 137.160
2013-05-30 2013-05-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7.894 12.466 172,66 0,95 7.499 11.843
2013-03-18 2013-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -24.058 0 -100,00
2013-03-18 2013-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -24.058 4.572 -84,03 25,00 -601.450 114.300
2013-03-18 2013-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 24.058 28.630 526,20 0,95 22.855 27.198
2013-03-11 2013-03-08 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -24.000 24.058 -49,94
2013-03-11 2013-03-08 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -24.000 4.572 -84,00 24,43 -586.270 111.684
2013-03-11 2013-03-08 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 24.000 28.572 524,93 0,95 22.800 27.143
2012-12-21 2012-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 100.000 100.000
2012-11-07 2012-11-05 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2012-10-11 2012-10-10 4 RGLS Regulus Therapeutics Inc.
Series A Preferred Stock
C - Conversion -6.150.500 0 -100,00
2012-10-11 2012-10-10 4 RGLS Regulus Therapeutics Inc.
Common Stock
C - Conversion 6.150.500 6.150.500
2012-06-07 2012-06-06 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 10.000 10.000
2012-02-23 2012-02-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 1.860 4.572 68,58 10,75 19.995 49.149
2011-10-13 2011-10-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase X 742 742 6,73 4.996 4.996
2007-01-10 3 ACOR ACORDA THERAPEUTICS INC
No securities are beneficially owned.
0
2004-12-09 2004-12-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 75.000 75.000
2004-05-27 3 ALNY ALNYLAM PHARMACEUTICALS INC
Common Stock
52.631
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)